PortfoliosLab logoPortfoliosLab logo
ARKG vs. IZRL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. IZRL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Israel Innovative Technology ETF (IZRL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than IZRL's 4.08% return.


ARKG

1D
-0.24%
1M
10.92%
YTD
17.09%
6M
10.02%
1Y
53.35%
3Y*
0.67%
5Y*
-15.72%
10Y*
7.22%

IZRL

1D
-2.54%
1M
1.92%
YTD
4.08%
6M
7.41%
1Y
29.75%
3Y*
20.69%
5Y*
0.63%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. IZRL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
17.09%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%0.51%
IZRL
ARK Israel Innovative Technology ETF
4.08%36.94%15.28%11.39%-38.61%-3.55%34.12%21.75%-6.17%1.69%

Correlation

The correlation between ARKG and IZRL is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.52

Correlation (3Y)
Calculated over the trailing 3-year period

0.60

Correlation (5Y)
Calculated over the trailing 5-year period

0.69

Correlation (All Time)
Calculated using the full available price history since Dec 6, 2017

0.68

The correlation between ARKG and IZRL shifts across timeframes, from 0.52 (1 year) to 0.69 (5 years), reflecting how their relationship changes across market environments.

ARKG vs. IZRL - Sectors Allocation Comparison


Sectors
ARKG
IZRL

Healthcare

99.2%
18.8%

Financial Services

0.5%
1.5%

Basic Materials

-

-

Communication Services

-

13.9%

Consumer Cyclical

-

6.8%

Consumer Defensive

-

1.5%

Energy

-

-

Industrials

-

7.7%

Real Estate

-

-

Technology

-

49.8%

Utilities

-

-

Healthcare

ARKG
99.2%
IZRL
18.8%

Financial Services

ARKG
0.5%
IZRL
1.5%

Basic Materials

ARKG

-

IZRL

-

Communication Services

ARKG

-

IZRL
13.9%

Consumer Cyclical

ARKG

-

IZRL
6.8%

Consumer Defensive

ARKG

-

IZRL
1.5%

Energy

ARKG

-

IZRL

-

Industrials

ARKG

-

IZRL
7.7%

Real Estate

ARKG

-

IZRL

-

Technology

ARKG

-

IZRL
49.8%

Utilities

ARKG

-

IZRL

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. IZRL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3535
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3737
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3232
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3838
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3131
Martin Ratio Rank

IZRL
IZRL Risk / Return Rank: 3636
Overall Rank
IZRL Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
IZRL Sortino Ratio Rank: 3939
Sortino Ratio Rank
IZRL Omega Ratio Rank: 3535
Omega Ratio Rank
IZRL Calmar Ratio Rank: 3333
Calmar Ratio Rank
IZRL Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. IZRL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Israel Innovative Technology ETF (IZRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARKGIZRLDifference
Sharpe ratioReturn per unit of total volatility

-0.08

Sortino ratioReturn per unit of downside risk

-0.06

Omega ratioGain probability vs. loss probability

1.22

1.24

-0.01

Calmar ratioReturn relative to maximum drawdown

1.95

1.64

+0.31

Martin ratioReturn relative to average drawdown

4.67

4.81

-0.15

ARKG vs. IZRL - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.31, which is comparable to the IZRL Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of ARKG and IZRL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ARKGIZRLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

1.39

-0.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

0.03

-0.37

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

0.26

-0.12

Drawdowns

ARKG vs. IZRL - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than IZRL's maximum drawdown of -59.98%. Use the drawdown chart below to compare losses from any high point for ARKG and IZRL.


Loading charts...

Drawdown Indicators


ARKGIZRLDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-59.98%

-23.61%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-18.27%

-9.24%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

-24.60%

-27.36%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

-53.21%

-26.97%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-69.65%

-15.42%

-54.23%

Average Drawdown

Average peak-to-trough decline

-35.87%

-25.77%

-10.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.46%

6.20%

+5.26%

Volatility

ARKG vs. IZRL - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 11.90% compared to ARK Israel Innovative Technology ETF (IZRL) at 6.12%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than IZRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARKGIZRLDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.90%

6.12%

+5.78%

Volatility (6M)

Calculated over the trailing 6-month period

28.77%

16.26%

+12.51%

Volatility (1Y)

Calculated over the trailing 1-year period

41.12%

21.57%

+19.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.61%

24.27%

+21.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.12%

24.84%

+16.28%

ARKG vs. IZRL - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is higher than IZRL's 0.49% expense ratio.


Dividends

ARKG vs. IZRL - Dividend Comparison

ARKG has not paid dividends to shareholders, while IZRL's dividend yield for the trailing twelve months is around 2.49%.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
IZRL
ARK Israel Innovative Technology ETF
2.49%2.59%0.45%0.00%0.00%0.34%0.00%2.15%3.08%0.00%

Frequently Asked Questions


ARKG and IZRL have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (11.90%) compared to IZRL (6.12%). In terms of maximum drawdown, ARKG dropped -83.59% vs IZRL's -59.98%.

On 5-year performance, IZRL leads with 0.63% vs -15.72% for ARKG. On fees, IZRL is cheaper at 0.49% per year. On volatility, IZRL has been the lower-risk option at 6.12%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IZRL has performed better with a 0.63% return vs -15.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IZRL is cheaper with a 0.49% expense ratio, compared with 0.75% for ARKG.

IZRL has the higher dividend yield at 2.49%, compared with 0.00% for ARKG.

ARKG is categorized as Health & Biotech Equities, while IZRL is Technology Equities. Their fees differ too: 0.75% for ARKG and 0.49% for IZRL.

IZRL currently has the higher Sharpe Ratio (1.39 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARKG and IZRL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer